Skip to main content

Table 2 Patient characteristics in CG and IG at baseline (t0)

From: Determine the impact of a structured pharmacist-led medication review - a controlled intervention study to optimise medication safety for residents in long-term care facilities

Characteristics

CG

IG

p value

Residents, total [n]

104

107

–

Residents, ownership by private association (5 wards), [n (%)]

40 (38%)

41 (38%)

0.983

Residents, municipal ownership (3 wards), [n (%)]

30 (29%)

34 (32%)

0.644

Residents, welfare ownership (3 wards), [n (%)]

34 (33%)

32 (30%)

0.663

Woman, [n (%)]

75 (72%)

72 (67%)

0.446

Age (years), median (Q25/Q75; Min-Max)

86 (78/90; 66–101)

86 (81/90; 66–100)

0.653

Length of residence (months), median (Q25/Q75; Min-Max)

31 (12/63; 1–414)

28 (12/58; 1–397)

0.437

Residents eligible alone for consent, [n (%)]

29 (28%)

34 (32%)

0.537

Residents required support for drug intake by nursing staff, [n (%)]

61 (59%)

66 (62%)

0.653

Residents with percutaneous endoscopic gastrostomy tubes (drugs must be administered by tube), [n (%)]

2 (2%)

1 (1%)

0.544

No. of chronic medications, median (Q25/Q75; Min-Max)

8 (6/10; 2–18)

7 (5/10; 2–16)

0.210

No. of PRN medications, median (Q25/Q75; Min-Max)

2 (1/3; 1–6)

2 (1/3; 1–8)

0.399

Documented diagnoses, median (Q25/Q75; Min-Max)

15 (10/21; 3–35)

14 (8/20; 3–37)

0.257

Dementia, [n (%)]

69 (66%)

69 (64%)

0.776

Diabetes, [n (%)]

41 (39%)

48 (45%)

0.424

Hypertension, [n (%)]

82 (79%)

87 (81%)

0.654

Renal failure, [n (%)]

24 (23%)

26 (24%)

0.835

Fecal incontinence, [n (%)]

16 (15%)

19 (18%)

0.643

Urinary incontinence, [n (%)]

39 (38%)

31 (29%)

0.188

  1. Abbreviations: Q25 first quartile, Q75 third quartile, CG control group, IG intervention group, Min minimum, Max maximum